GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Vidac Pharma Holding PLC (STU:T9G) » Definitions » Price-to-Owner-Earnings

Vidac Pharma Holding (STU:T9G) Price-to-Owner-Earnings : (As of May. 21, 2025)


View and export this data going back to 2023. Start your Free Trial

What is Vidac Pharma Holding Price-to-Owner-Earnings?

As of today (2025-05-21), Vidac Pharma Holding's share price is €0.492. Vidac Pharma Holding does not have enough data to calculate Owner Earnings per Share (TTM), so as pPrice-to-Owner-Earnings.


The historical rank and industry rank for Vidac Pharma Holding's Price-to-Owner-Earnings or its related term are showing as below:


STU:T9G's Price-to-Owner-Earnings is not ranked *
in the Biotechnology industry.
Industry Median: 29.47
* Ranked among companies with meaningful Price-to-Owner-Earnings only.

As of today (2025-05-21), Vidac Pharma Holding's share price is €0.492. Vidac Pharma Holding's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2024 was €-0.03. Therefore, Vidac Pharma Holding's PE Ratio (TTM) for today is At Loss.

As of today (2025-05-21), Vidac Pharma Holding's share price is €0.492. Vidac Pharma Holding's EPS without NRI for the trailing twelve months (TTM) ended in was €-0.03. Therefore, Vidac Pharma Holding's PE Ratio without NRI for today is At Loss.


Vidac Pharma Holding Price-to-Owner-Earnings Historical Data

The historical data trend for Vidac Pharma Holding's Price-to-Owner-Earnings can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Vidac Pharma Holding Price-to-Owner-Earnings Chart

Vidac Pharma Holding Annual Data
Trend Dec21 Dec22 Dec23
Price-to-Owner-Earnings
- - -

Vidac Pharma Holding Semi-Annual Data
Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Price-to-Owner-Earnings Get a 7-Day Free Trial - - - - -

Competitive Comparison of Vidac Pharma Holding's Price-to-Owner-Earnings

For the Biotechnology subindustry, Vidac Pharma Holding's Price-to-Owner-Earnings, along with its competitors' market caps and Price-to-Owner-Earnings data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Vidac Pharma Holding's Price-to-Owner-Earnings Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Vidac Pharma Holding's Price-to-Owner-Earnings distribution charts can be found below:

* The bar in red indicates where Vidac Pharma Holding's Price-to-Owner-Earnings falls into.


;
;

Vidac Pharma Holding Price-to-Owner-Earnings Calculation

In 1986 Berkshire Hathaway Shareholder Letter, Warren Buffett defined owner earnings as follows:

"These represent (a) reported earnings plus (b) depreciation, depletion, amortization, and certain other non-cash charges...less (c) the average annual amount of capitalized expenditures for plant and equipment, etc. that the business requires to fully maintain its long-term competitive position and its unit volume. (If the business requires additional working capital to maintain its competitive position and unit volume, the increment also should be included in (c))...Our owner-earnings equation does not yield the deceptively precise figures provided by GAAP, since (c) must be a guess - and one sometimes very difficult to make. Despite this problem, we consider the owner earnings figure, not the GAAP figure, to be the relevant item for valuation purposes - both for investors in buying stocks and for managers in buying entire businesses...All of this points up the absurdity of the 'cash flow' numbers that are often set forth in Wall Street reports. These numbers routinely include (a) plus (b) - but do not subtract (c)."

Vidac Pharma Holding's Price-to-Owner-Earnings for today is calculated as

Price-to-Owner-Earnings=Share Price/Owner Earnings per Share (TTM)
=0.492/0.00
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Vidac Pharma Holding  (STU:T9G) Price-to-Owner-Earnings Explanation

For how to get Owner Earnings per Share (TTM), please click.


Vidac Pharma Holding Price-to-Owner-Earnings Related Terms

Thank you for viewing the detailed overview of Vidac Pharma Holding's Price-to-Owner-Earnings provided by GuruFocus.com. Please click on the following links to see related term pages.


Vidac Pharma Holding Business Description

Traded in Other Exchanges
N/A
Address
Wenlock Road, 20-22, London, GBR, N1 7GU
Vidac Pharma Holding PLC is a clinical-stage biopharmaceutical company developing first-in-class oncologic and onco-dermatologic therapies. Its drug, VDA-1102, is at the clinical development stage as an ointment for patients with actinic keratosis, an early form of skin cancer, and in a separate trial for an indication of cutaneous T-cell lymphoma (CTCL). A second molecule, VDA-1275, with possible application for a wide range of solid tumors.

Vidac Pharma Holding Headlines

No Headlines